Glenmark Pharmaceuticals - Multibagger Trgt 750 Rs in 2 yrs

• Glenmark  a leading company in discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecules in various stages of clinical development & pre-clinical development.
• Glenmark  revenue is of USD 32 Million, the company is currently ranked among the World's top 100 Pharma & Biotech companies.
• SCRIP  a leading magazine had  recognized Glenmark as 'Best Pharma Company in the World – SME' and 'Best Company in an Emerging Market' in 2008.
• Company has 14 manufacturing facilities in four countries and has 6 R&D centres.
• With strong growth we expect the company to deliver 40 % growth.
• One can buy with Trgt with 750 Rs.